CymitQuimica logo

DL-threo-Ritalinic acid

CAS:

Ref. 3D-IR180350

1mg
Discontinued
5mg
Discontinued
10mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

DL-threo-Ritalinic acid
Biosynth

Product Information

Name:DL-threo-Ritalinic acid
Controlled Product
Brand:Biosynth
Description:DL-threo-Ritalinic Acid is a dopamine receptor agonist that has been shown to be effective in treating hyperactivity, or attention deficit disorder (ADHD). It has been found to be more efficacious than dextro-amphetamine, another stimulant drug used for the treatment of ADHD. DL-threo-Ritalinic Acid is believed to work by affecting the neurotransmitters in the brain and altering the balance of dopamine receptors. In a two-way crossover study, preschool children were given either 0.5mg/kg of DL-threo-Ritalinic Acid or placebo for three days. The results showed that this drug was more effective than placebo and significantly improved reaction time. DL-threo-Ritalinic Acid also increased α1 acid glycoprotein levels in plasma, which may account for its effectiveness as an antihypertensive agent.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:219.28 g/mol
Formula:C13H17NO2
Purity:Min. 95%

Inquiry about discontinued product: DL-threo-Ritalinic acid

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.